Lv2
160 积分 2026-03-25 加入
A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes
8天前
已完结
PBPK Models for Fetal Drug Exposure: A Critical Assessment of Current Approaches and Regulatory Readiness
12天前
已完结
Diffuse Large B Cell Lymphoma Presenting as a Cardiac Mass Complicated by Atrial Arrhythmia
1个月前
已完结
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
1个月前
已完结
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM×anti-CD3) as a targeted cancer immunotherapy
1个月前
已完结
Catumaxomab: First Approval
1个月前
已完结
Catumaxomab: clinical development and future directions
1个月前
已完结
Review of catumaxomab in the treatment of malignant ascites
1个月前
已完结
Evaluation of the potential impact on pharmacokinetics of various cytochrome P450 substrates of increasing IL-6 levels following administration of the T-cell bispecific engager glofitamab
1个月前
已完结
A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma
1个月前
已完结
皖公网安备34019202002308
